Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Mounjaro is a prescription medicine used to support weight management. It is also licensed for type
2 diabetes. It works best when combined with healthy eating, increased activity, and regular
medical follow-up.
■ How Does it Work?
Mounjaro works by mimicking two natural hormones in the body, GLP-1 and GIP. Together they
help to:
• Reduce appet
Mounjaro is a prescription medicine used to support weight management. It is also licensed for type
2 diabetes. It works best when combined with healthy eating, increased activity, and regular
medical follow-up.
■ How Does it Work?
Mounjaro works by mimicking two natural hormones in the body, GLP-1 and GIP. Together they
help to:
• Reduce appetite – you feel full sooner and stay full longer
• Slow down stomach emptying – food stays in your stomach longer
• Improve blood sugar control – especially helpful if you have diabetes or are at risk
■ How Do I Take It?
Mounjaro comes as a once-weekly injection using a pen device. It is injected under the skin
(tummy, thigh, or upper arm). You can take it at any time of day, with or without food.
Week Dose
1–4 2.5 mg once weekly (starting dose)
5–8 5 mg once weekly
9–12 7.5 mg once weekly
13–16 10 mg once weekly
17–20 12.5 mg once weekly
21+ 15 mg once weekly (maximum dose)
■ Tips for Taking Mounjaro
• Inject once a week, on the same day each week
• Rotate injection sites each week
• If you miss a dose, take it within 4 days; if more than 4 days have passed, skip it and continue
as normal
• Store unused pens in the fridge; once in use, pens can be kept at room temperature (up to
30°C) for 21 days
■ Common Side Effects
• Nausea, vomiting, diarrhoea, or constipation
• Reduced appetite
• Tiredness or headache
• Mild redness or swelling at the injection site
Contact your doctor if symptoms are severe, persistent, or if you notice abdominal pain that does
not go away.
■ Monitoring
Your doctor will review your weight, progress, and any side effects regularly. Treatment may be
adjusted depending on how you respond. Progress is usually checked after 16 weeks on the 5 mg
dose or higher.
https://www.medicines.org.uk/emc/files/pil.15481.pdf
Wegovy is a prescription medicine used for weight management. It works best when combined with
healthy eating, increased activity, and regular medical follow-up.
■ How Does it Work?
Wegovy mimics a natural hormone in the body called GLP-1. It works in several ways to support
weight loss:
• Reduces appetite – helping you feel full sooner and st
Wegovy is a prescription medicine used for weight management. It works best when combined with
healthy eating, increased activity, and regular medical follow-up.
■ How Does it Work?
Wegovy mimics a natural hormone in the body called GLP-1. It works in several ways to support
weight loss:
• Reduces appetite – helping you feel full sooner and stay full longer
• Slows down stomach emptying – food stays in your stomach longer
• Supports blood sugar control – reducing cravings and stabilising energy levels
■ How Do I Take It?
Wegovy is taken once a week as an injection under the skin (in your tummy, thigh, or upper arm).
You can take it at any time of day, with or without food.
Weeks Dose
1–4 0.25 mg once weekly
5–8 0.5 mg once weekly
9–12 1.0 mg once weekly
13–16 1.7 mg once weekly
17+ 2.4 mg once weekly (maintenance dose)
■ Tips for Taking Wegovy
• Inject once a week, on the same day each week
• Rotate injection sites each week
• If you miss a dose and it is within 5 days, take it as soon as possible. If more than 5 days
have passed, skip it and continue as normal
• Store unused pens in the fridge; once in use, pens can be kept at room temperature (up to
30°C) for 6 weeks
■ Common Side Effects
• Nausea, vomiting, diarrhoea, or constipation
• Headache or tiredness
• Mild redness or swelling at the injection site
Contact your doctor if symptoms are severe, persistent, or if you notice abdominal pain that does
not go away.
■ Monitoring
Your doctor will review your weight, progress, and any side effects regularly. Treatment is usually
reassessed after 16 weeks on the 2.4 mg dose to check effectiveness.
Saxenda is a prescription medicine used to support weight management. It works best when
combined with healthy eating, increased activity, and regular medical follow-up.
■ How Does it Work?
Saxenda is similar to a natural hormone in the body called GLP-1. It helps to:
• Reduce appetite – you feel full sooner and stay full longer
• Slow down st
Saxenda is a prescription medicine used to support weight management. It works best when
combined with healthy eating, increased activity, and regular medical follow-up.
■ How Does it Work?
Saxenda is similar to a natural hormone in the body called GLP-1. It helps to:
• Reduce appetite – you feel full sooner and stay full longer
• Slow down stomach emptying – food stays in your stomach longer
• Support blood sugar control – helpful if you are at risk of diabetes
■ How Do I Take It?
Saxenda comes as a daily injection using a pen device. It is injected under the skin (tummy, thigh,
or upper arm).
Week Dose
1 0.6 mg once daily
2 1.2 mg once daily
3 1.8 mg once daily
4 2.4 mg once daily
5+ 3.0 mg once daily (usual full dose)
■ Tips for Taking Saxenda
• Take it at the same time each day, with or without food
• Rotate injection sites each day
• Store unused pens in the fridge; once in use, can be kept at room temperature for 30 days
• Never share your pen with anyone else
■ Common Side Effects
• Nausea, vomiting, diarrhoea, or constipation
• Headache or tiredness
• Mild redness or swelling at the injection site
Contact your doctor if symptoms are severe, persistent, or if you notice abdominal pain that does
not go away.
■ Monitoring
You will have regular follow-up with your doctor to review your progress, weight loss, and any side
effects. Treatment is usually reassessed after 16 weeks to check effectiveness.
LBP4.086
Innovative Digital Weight Management: Real-World Outcomes
from Weight Loss Wales
Davies, A. L.
Clinical Director, Weight Loss Wales, United Kingdom
Obesity remains a significant public health burden in the UK, with prev-
alence continuing to rise, leading to increased rates of type 2 diabetes,
cardiovascular disease, and reduced quality of life. Despite the growing
availability of pharmacological treatments, adherence to anti-obesity
medications remains a challenge, necessitating smarter, more innovative
approaches to ensure safe and effective weight management.
Weight Loss Wales became the first Healthcare Inspectorate Wales accred-
ited and approved virtual weight management clinic in Wales, utilizing
a fully digital approach to patient consultations. By integrating virtual
assessments with close, ongoing patient engagement via WhatsApp, text
messaging, and email, the service provided continuous support while
optimizing adherence to treatment.
This study presents real-world data from the first 100 patients initiated on
semaglutide or tirzepatide for weight management. Key findings include:
• 96% of patients remained on treatment for at least six months.
• The average weight loss at six months was 19kg, demonstrating signif-
icant efficacy.
• The average dose of tirzepatide used was 7.7mg, highlighting a gradual
patient centric titration approach within a virtual setting.
Davies, A.L. (2025) ‘Innovative digital weight management: real-world outcomes from Weight Loss Wales’, Obesity Facts, 18(Suppl 1), p. LBP4.086. Presented at the 32nd European Congress on Obesity (ECO 2025), Málaga, Spain, 11–14 May. doi:10.1159/000545968.
Acquisition costs and weight reduction
Evans, M., Evans, W., Godbeer, F., Edgar, L., Spaepen, E. and Davies, A.L. (2025) ‘Analysis of tirzepatide acquisition costs and weight reduction outcomes in the United Kingdom: insights from the SURMOUNT-1 study’, Advances in Therapy, 42(6), pp. 2821–2832. doi:10.1007/s12325-025-03194-8.
Wang, W., Chen, R., Lloyd Davies, A., Guo, J., Bo Jensen, T., Li, Y., Luo, B., Ye, X., Zhang, K. and Ning, G. (2023)‘IDF2022-0613 PIONEER 11: Efficacy and safety of oral semaglutide versus placebo in predominantly Chinese patients with T2D treated with diet and exercise’, Diabetes Research and Clinical Practice, 197 (Suppl 1), 110316. doi:10.1016/j.diabres.2023.110316.
Knop, F.K., Cariou, B., Christiansen, E., Davies, A.L., Montanya, E., Abildlund, M.T. & Rosenstock, J. (2021) ‘Time spent in glycaemic control after initiating treatment with oral semaglutide vs empagliflozin: an exploratory analysis of the PIONEER 2 trial’. 57th Annual Meeting of the European Association for the Study of Diabetes (EASD 2021), Abstract 480, pp. 249–250.
Davies, A.L., Khunti, K., Capehorn, M., Artime, E., Spaepen, E., Adam, A., Lin, X., Shang, M., Seager, S. and von Arx, L.-b. (2024) ‘The UK Obesity Landscape: Results from the UK Primary Care Cohort of the IMPACT-O Study’, International Journal of Obesity, 48(Suppl 1), P84. doi:10.1038/s41366-023-01431-0.
Mounjaro v Wegovy
Tirzepatide 10 and 15 mg were associated with statistically significant
greater reductions in weight, BMI and HbA1c versus semaglutide.
Mounjaro v Wegovy
The pooled analysis showed greater
weight loss with tirzepatide compared to semaglutide
Mysimba is a prescription-only oral medication used alongside a reduced-calorie diet and increased
physical activity. It is licensed for adults with BMI ≥30, or BMI ≥27 with a weight-related condition
such as type 2 diabetes, high blood pressure, or dyslipidaemia.
■ How Does it Work?
Mysimba combines two medicines – naltrexone and bupropion – that act on the brain to:
• Reduce appetite and cravings
• Help you feel full with less food
■ How Do I Take It?
Mysimba is taken as tablets by mouth. The dose is increased gradually over 4 weeks.
Week Dose
1 1 tablet in the morning
2 1 in the morning + 1 in the evening
3 2 in the morning + 1 in the evening
4+ 2 in the morning + 2 in the evening (maximum dose)
■ Effectiveness & Review
Treatment should be stopped after 16 weeks if you have not lost at least 5% of your starting weight.
Studies show average weight loss of around 8% after 56 weeks with Mysimba.
■ Common Side Effects
• Nausea, vomiting, constipation
• Headache, dizziness, dry mouth
• Insomnia (trouble sleeping)
■■ Mysimba may cause drowsiness or dizziness. Do not drive or operate machinery until you know
how it affects you.
■ Monitoring
Regular follow-up with your doctor is important to review progress, side effects, and whether
treatment should continue.
Orlistat is a medicine used to help with weight loss. It works best when combined with a
reduced-calorie diet and regular physical activity. It is suitable for adults with a BMI ≥30, or BMI ≥28
with a weight-related health condition.
■ How Does it Work?
Orlistat works in your digestive system by blocking the absorption of around one-third of the fat from
the food you eat. This undigested fat passes through the gut and out of the body in your stool. By
reducing the calories you absorb from fat, Orlistat helps with weight loss.
■ How Do I Take It?
• The usual dose is 120 mg three times a day.
• Take immediately before, during, or up to 1 hour after a main meal containing fat.
• If a meal is missed or contains no fat, skip the dose.
• Swallow the capsule whole with water.
■ Tips for Taking Orlistat
• Follow a balanced, reduced-calorie diet with about 30% of calories from fat.
• Spread your daily fat intake evenly across three meals.
• Take a daily multivitamin at bedtime (or at least 2 hours after taking Orlistat) to prevent
vitamin deficiencies (A, D, E, K).
■ Common Side Effects
• Oily or fatty stools
• Urgent or increased bowel movements
• Flatulence with oily spotting
• Abdominal discomfort
These side effects are more likely if you eat a high-fat meal.
■ Monitoring
Your doctor will review your progress after 12 weeks. If you have not lost at least 5% of your
starting weight, treatment may be stopped. Regular follow-up ensures safe and effective use.
The most common side effects observed in clinical trials were nausea and diarrhoea, these were mild/moderate in severity, and usually of short duration and most frequently reported during the first few months on treatment.
Read the patient leaflet and information you have been provided and contact us on the number you have been given or via the contact us page.
Following the 4th dose of Tirzepatide there will be a quantity of solution left in the pen device.
Patients have the autonomy to choose their preferred exercise modality, thereby optimizing treatment outcomes. In addition, this novel systematic review included a dose-response meta-analysis, which showed that aerobic exercise required 140 min per week to improve depressive symptoms